Cargando…

Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019

BACKGROUND: There is considerable variation in reported chronic obstructive pulmonary disease (COPD) prevalence internationally, partly due to differing definitions in use. Accurate estimates of disease prevalence are important for allocation of health-care resources, yet UK estimates of COPD preval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stone, Philip W, Osen, Michael, Ellis, Andrew, Coaker, Rebecca, Quint, Jennifer K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368107/ https://www.ncbi.nlm.nih.gov/pubmed/37497381 http://dx.doi.org/10.2147/COPD.S411739

Ejemplares similares

Burden and treatment of chronic obstructive pulmonary disease among people using illicit opioids: matched cohort study in England
por: Lewer, Dan, et al.
Publicado: (2022)

Validation of acute exacerbation of chronic obstructive pulmonary disease (COPD) recording in electronic health records: a systematic review protocol
por: Stone, Philip, et al.
Publicado: (2020)

All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD)
por: Raslan, Abdul Sattar, et al.
Publicado: (2023)

Comparison of COPD primary care in England, Scotland, Wales, and Northern Ireland
por: Stone, Philip W., et al.
Publicado: (2022)

Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England
por: Nacul, Luis C, et al.
Publicado: (2007)

Prevalence of cardiovascular disease in subjects hospitalized due to chronic obstructive pulmonary disease in Beijing from 2000 to 2010
por: Cui, Hua, et al.
Publicado: (2012)

Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes
por: Rothnie, Kieran J., et al.
Publicado: (2016)

Chronic Obstructive Pulmonary Disease (COPD) in Population Studies in Russia and Norway: Comparison of Prevalence, Awareness and Management
por: Cook, Sarah, et al.
Publicado: (2021)

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
por: Requena, Gema, et al.
Publicado: (2023)

Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol
por: Morgan, Ann D, et al.
Publicado: (2016)

Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England
por: Requena, Gema, et al.
Publicado: (2023)

Revisiting the one in four: the prevalence of psychiatric disorder in the population of England 2000–2014
por: Bebbington, Paul E., et al.
Publicado: (2019)

Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records
por: Whittaker, Hannah, et al.
Publicado: (2023)

Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
por: Utens, Cecile M.A, et al.
Publicado: (2012)

An observational cohort study of exercise and education for people with chronic obstructive pulmonary disease not meeting criteria for formal pulmonary rehabilitation programmes
por: Lewis, A, et al.
Publicado: (2019)

Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England
por: Morgan, Ann, et al.
Publicado: (2023)

Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England
por: Czira, Alexandrosz, et al.
Publicado: (2023)

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease
por: Quint, Jennifer K, et al.
Publicado: (2012)

Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Axson, Eleanor L, et al.
Publicado: (2020)

Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review
por: Whittaker, Hannah R., et al.
Publicado: (2019)

Effect of time and day of admission on hospital care quality for patients with chronic obstructive pulmonary disease exacerbation in England and Wales: single cohort study
por: Roberts, Christopher Michael, et al.
Publicado: (2017)

From Bumps to Binges: Overview of Deaths Associated with Cocaine in England, Wales and Northern Ireland (2000–2019)
por: Rooney, Brian, et al.
Publicado: (2023)

Incidence of type II diabetes in chronic obstructive pulmonary disease: a nested case–control study
por: Gayle, Alicia, et al.
Publicado: (2019)

Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study
por: Hurst, John R, et al.
Publicado: (2010)

Predicting mortality after acute coronary syndromes in people with chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2016)

Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England
por: Sansbury, Leah B, et al.
Publicado: (2022)

Incidence and Prevalence of Chronic Obstructive Pulmonary Disease among Aboriginal Peoples in Alberta, Canada
por: Ospina, Maria B., et al.
Publicado: (2015)

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers
por: Sansores, Raúl H, et al.
Publicado: (2015)

High prevalence of chronic obstructive pulmonary disease in Korea
por: Rhee, Chin Kook
Publicado: (2016)

The prevalence of chronic obstructive pulmonary disease in hookah smokers
por: Bahtouee, Mehrzad, et al.
Publicado: (2017)

Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic
por: Sculley, Jennifer A., et al.
Publicado: (2022)

Predictors of pulmonary rehabilitation completion in the UK
por: Stone, Philip W., et al.
Publicado: (2021)

Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease
por: Whittaker, Hannah R, et al.
Publicado: (2020)

Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors
por: Zhang, Jingzhou, et al.
Publicado: (2021)

Trends in the Annual Consultation Incidence and Prevalence of Low Back Pain and Osteoarthritis in England from 2000 to 2019: Comparative Estimates from Two Clinical Practice Databases
por: Yu, Dahai, et al.
Publicado: (2022)

Prevalence of Bovine Viral Diarrhea Virus Infection in Japan: 2000–2019
por: Tajima, Motoshi
Publicado: (2021)

Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)
por: Quint, Jennifer K, et al.
Publicado: (2014)

Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study
por: Adams, Elisabeth J, et al.
Publicado: (2023)

Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease
por: Rothnie, Kieran J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qg2o8be3nn6861sog078t80a5e